Cloé Esposito graduated with a degree in Biochemistry from Aix-Marseille Université - Faculté des Sciences in 2013, and with a MSc in Analytical development and biopharmaceutics at Claude Bernard Université, Lyon 1- Faculté de Pharmacie in 2016. She has been working at the Université de Montréal for two, years developing organogels and nanogels for the delivery of therapeutics. She is currently pursuing her thesis work with Drs Sylvie Marleau and Plamen Kirilov regarding the development of drug delivery tools for the management of chronic inflammation. Her research interests range from material science developing new delivery systems to biomedical applications. She was part of the FIP Young Scientists Conference Committee and is currently an AAPS member.
Cloé Esposito graduated with a degree in Biochemistry from Aix-Marseille Université - Faculté des Sciences in 2013, and with a MSc in Analytical development and biopharmaceutics at Claude Bernard Université, Lyon 1- Faculté de Pharmacie in 2016. She has been working at the Université de Montréal for two, years developing organogels and nanogels for the delivery of therapeutics. She is currently pursuing her thesis work with Drs Sylvie Marleau and Plamen Kirilov regarding the development of drug delivery tools for the management of chronic inflammation. Her research interests range from material science developing new delivery systems to biomedical applications. She was part of the FIP Young Scientists Conference Committee and is currently an AAPS member.